About
Biologics
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (37)
View allTotal Trials
37
As Lead Sponsor
29
As Collaborator
8
Total Enrollment
8,368
By Phase
PHASE2: 14PHASE1: 8PHASE3: 8PHASE4: 3NA: 2PHASE1/PHASE2: 1
By Status
UNKNOWN: 16COMPLETED: 8NOT_YET_RECRUITING: 6RECRUITING: 3TERMINATED: 2ACTIVE_NOT_RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline37 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
Hover over trial bars to see details
Recent Trials
NCT06781086Lead Sponsor
Nimotuzumab Combined With Nab-paclitaxel/Gemcitabine in the Perioperative Treatment of High-risk Resectable/Borderline Resectable Pancreatic Cancer
PHASE2Not yet recruiting
156 participants
Started: Jan 20, 2025 · Completed: Dec 31, 2028
NCT06633055Lead Sponsor
A Phase I Clinical Trial of JH013 Injection
PHASE1Not yet recruiting
32 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2025
NCT06348264Collaborator
Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma
PHASE2Recruiting
37 participants
Started: Oct 10, 2024 · Completed: Mar 30, 2031
NCT05978050Lead Sponsor
Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma
PHASE3Recruiting
354 participants
Started: Aug 1, 2024 · Completed: Mar 1, 2026
NCT06543550Lead Sponsor
Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis
PHASE4Recruiting
70 participants
Started: Jul 30, 2024 · Completed: Oct 31, 2025
Locations (1)
Headquarters
Dreieich, Germany
Map
Loading map...